ProFound Therapeutics

Patient using blood pressure monitor
#Cardiovascular disease #Collaboration #Novartis #ProFound Therapeutics

Novartis and ProFound agree cardiovascular collaboration

Novartis and ProFound Therapeutics have announced a four-year collaboration to discover and develop novel therapeutics for cardiovascular disease.  The collaboration will join ProFound’s capabilities in the identification of novel proteins from the expanded proteome as drugs and drug targets with Novartis’ cardiovascular drug development expertise. … Read More

#Business & Investment #News

Weight loss and obesity
#Collaboration #Flagship Pioneering #Obesity #Pfizer #ProFound Therapeutics

Breakthrough drug discovery research collaboration in obesity

Flagship Pioneering and ProFound Therapeutics have announced a collaboration to conduct foundational research to identify potential next-generation first-in-class therapies for the treatment of obesity. The collaboration is the first initiated under Flagship’s Pioneering Medicines strategic partnership with Pfizer announced in July 2023. Pioneering Medicines,… Read More

#News